Anti-mesothelin thorium-227 labeled antibody chelator conjugate

N/A

Report date: 2025/09/24 17:41:48

Base Information

Drug NameAnti-mesothelin thorium-227 labeled antibody chelator conjugate

Drug Alias NameThorium (227Th) anetumab corixetanBAY-2287411

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody diagnosticsRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Thorium > 227Th +[4]

Mechanisms of ActionMesothelin inhibitors

TargetsMesothelin

Therapy Area/IndicationsOvarian NeoplasmsCarcinoma, Pancreatic DuctalMesothelioma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesSwedenNetherlands +[5]

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesBayer AG

China Registration ClassN/A

Develop Information

Active CompaniesBayer AG

Inactive CompaniesN/A

Active IndicationsOvarian NeoplasmsCarcinoma, Pancreatic DuctalMesothelioma

Inactive IndicationsN/A

Other Information

ATC CodeN/A